OneOncology, the platform for independent oncology practices, said today that partner practice physicians and other OneOncology experts will make 23 presentations across 12 different subject categories at the 2021 ASCO Annual Meeting from June 4-6. OneOncology’s model combines private equity-backed scale with localized oncologist control and community presence. The group continues to expand its research program offering industry sponsors and contract research organizations (CROs) compelling oncology-centric clinical research as a care option for access to novel therapeutic trials. Now leadership visits the forthcoming ASCO to discuss ongoing research and care option initiatives in oncology.
Lee Schwartzberg, MD, Chief Medical Officer, OneOncology, is an author on six abstracts and Axel Grothey, MD, Medical Director, OneR, Director of GI Cancer Research at the West Cancer Center, is the author on 12 abstracts. OneR is OneOncology’s clinical trial site management organization launched last year.
Drs. Grothey, Schwartzberg and Ari VanderWalde, Medical Director of Precision Oncology at OneR and Director of Research at West Cancer Center are authors on an abstract evaluatin...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).